MRNA
+$177.4K
9,263 sh @ $19
AFEYAN NOUBAR
Director, 10% Owner · SEC CIK 1222012Advertisement
Buy track record
How this insider's open-market purchases have performed8%
of buys now in profit
1 up · 12 down
Avg return since buy−92.1%
Median return−100.0%
Best trade+1.7%
Worst trade−100.0%
Buys scored13
Average return by holding period — separates good entry timing from riding one long winner
After 1 month
+1.0%
8% won · 13 trades
After 3 months
−0.1%
0% won · 13 trades
After 6 months
+0.0%
0% won · 12 trades
After 12 months
+0.0%
0% won · 12 trades
| Date | Company | 90d trend | Buy price | Value | ΔOwn | 1M | 3M | 6M | 12M | To date |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | GENB | $16 | $25M | NEW | +13.0% | −1.6% | — | — | +1.7% | |
| Jan 30, 2013 | BGMD | $2 | $500K | +11% | +0.0% | +0.0% | +0.0% | +0.0% | −100.0% | |
| Jan 30, 2013 | BGMD | $2 | $250K | +24% | +0.0% | +0.0% | +0.0% | +0.0% | −100.0% | |
| Jan 30, 2013 | BGMD | $2 | $150K | +54% | +0.0% | +0.0% | +0.0% | +0.0% | −100.0% | |
| Jan 30, 2013 | BGMD | $2 | $1M | +21% | +0.0% | +0.0% | +0.0% | +0.0% | −100.0% | |
| Jan 30, 2013 | BGMD | $2 | $2.1M | +147% | +0.0% | +0.0% | +0.0% | +0.0% | −100.0% | |
| Feb 9, 2011 | BGMD | $7 | $250K | +7.3% | +0.0% | +0.0% | +0.0% | +0.0% | −100.0% | |
| Feb 9, 2011 | BGMD | $7 | $75K | +3.7% | +0.0% | +0.0% | +0.0% | +0.0% | −100.0% | |
| Feb 9, 2011 | BGMD | $7 | $150K | +30% | +0.0% | +0.0% | +0.0% | +0.0% | −100.0% | |
| Feb 9, 2011 | BGMD | $7 | $100K | +11% | +0.0% | +0.0% | +0.0% | +0.0% | −100.0% | |
| Feb 9, 2011 | BGMD | $7 | $1.9M | +13% | +0.0% | +0.0% | +0.0% | +0.0% | −100.0% | |
| Feb 9, 2011 | BGMD | $7 | $300K | +2.0% | +0.0% | +0.0% | +0.0% | +0.0% | −100.0% | |
| Feb 9, 2011 | BGMD | $7 | $5M | NEW | +0.0% | +0.0% | +0.0% | +0.0% | −100.0% |
How this is calculated. We score only open-market purchases (SEC code
P) — the buys that carry real signal. Each trade's return is measured from the adjusted closing price on the purchase date to the latest close, accounting for stock splits and dividends. The 1M/3M/6M/12M columns show the same trade's return after each fixed holding period; a dash means that horizon hasn't elapsed yet or isn't priceable. Sales are excluded because insiders sell for many routine reasons. With only 13 scored trades, treat this as a small sample, not a verdict.
Advertisement
Open-market buys
$36.78M
13 trades
Open-market sells
$106.6M
165 trades
Net flow
−$69.82M
Net selling
Total filings
182
transactions shown
Full transaction history
All Form 4 activity across every company, newest firstMRNA
−$433.9K
9,263 sh @ $47
GENB
+$0
2.78M sh
GENB
Afeyan Noubar, GENB's 10% owner, spent $25M of their own money on 1.56M shares at $16, opening a brand-new position.
+$25M
1.56M sh @ $16
MRNA
+$260K
23,853 sh @ $11
Advertisement
MRNA
−$703.3K
23,853 sh @ $29
MRNA
−$547.1K
4,599 sh @ $119
MRNA
−$678.8K
5,664 sh @ $120
MRNA
−$414.4K
3,428 sh @ $121
MRNA
−$159.2K
1,309 sh @ $122
MRNA
−$310.4K
2,668 sh @ $116
MRNA
−$410.4K
3,500 sh @ $117
MRNA
−$808.2K
6,832 sh @ $118
MRNA
−$238K
2,000 sh @ $119
MRNA
−$314.3K
2,601 sh @ $121
MRNA
−$255.3K
2,100 sh @ $122
MRNA
−$356.3K
2,900 sh @ $123
MRNA
−$829.5K
6,699 sh @ $124
MRNA
−$87.2K
700 sh @ $125
MRNA
−$710.1K
6,121 sh @ $116
MRNA
−$501.4K
4,279 sh @ $117
MRNA
−$353.5K
3,000 sh @ $118
MRNA
−$131.2K
1,100 sh @ $119
MRNA
−$60K
500 sh @ $120
MRNA
−$301.8K
2,460 sh @ $123
MRNA
−$198K
1,600 sh @ $124
MRNA
−$187.4K
1,500 sh @ $125
MRNA
−$138.3K
1,100 sh @ $126
MRNA
−$140.3K
1,100 sh @ $128
MRNA
−$184.8K
1,435 sh @ $129
Frequently asked questions
How is AFEYAN NOUBAR's win rate calculated?
We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.
Why are some buys not included in the score?
A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.
What do the 1M / 3M / 6M / 12M columns mean?
They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.
Does a high win rate mean I should copy this insider?
No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.
Where does this data come from?
Trades come from AFEYAN NOUBAR's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.